Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Anthim Market Report 2025

Anthim Global Market Report 2025 – By Type (Adult, Children), By Clinical Indications (Inhalational Anthrax Treatment, Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax, Use In Pediatric And Adult Populations), By Application (Hospital, Drugs Store, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Anthim Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Anthim Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Anthim Market Definition

Anthim is a monoclonal antibody used to treat inhalational anthrax caused by Bacillus anthracis infection. It works by binding to the anthrax toxin, preventing it from entering cells and causing damage.

The main types of anthim are adult and Children. Anthim (obiltoxaximab) is indicated for use in adults as part of the treatment regimen for inhalational anthrax caused by Bacillus anthracis. The incical indication involved are inhalational anthrax treatment, post-exposure prophylaxis (pep) for inhalational anthrax, use in pediatric and adult population. The various applications involved are hospital, drugs store, and other applications.

Anthim Market Segmentation

The anthimmarket covered in this report is segmented –

1) By Type: Adult, Children

2) By Clinical Indications: Inhalational Anthrax Treatment, Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax, Use In Pediatric And Adult Populations

3) By Application: Hospital, Drugs Store, Other Applications

Anthim Market Size and growth rate 2025 to 2029: Graph

Anthim Market Size 2025 And Growth Rate

The anthim market size has grown strongly in recent years. It will grow from $3,994.45 million in 2024 to $4,300.44 million in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to government initiatives for emergency stockpiling, advancements in monoclonal antibody production technologies, heightened global awareness of biological threats, and the rising need for innovative therapeutic approaches in infectious disease management.

Anthim Market Growth Forecast

The anthim market size is expected to see strong growth in the next few years. It will grow to $5,715.28 million in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to enhancing monoclonal antibody production, expanding healthcare infrastructure in emerging markets, and increasing global awareness of biological threat mitigation strategies. Major trends in the forecast period include advanced biopharmaceutical research, expanding public-private partnerships in biodefense initiatives, rising regional diversification in pharmaceutical production, and an emphasis on streamlined regulatory pathways to accelerate drug approval processes.

Book your 30 minutes free consultation with our research experts

Contact Us

Anthim Market Driver: Impact Of Rising Bacterial Disease Prevalence On The Growth Of The ANTHIM Market

The rising prevalence of bacterial infections is expected to propel the growth of the anthim market going forward. Bacterial infections refer to diseases caused by harmful bacteria that invade the body, multiply, and produce toxins. The rise in bacterial infections stems from antibiotic overuse, global travel, urbanization, poor hygiene, and healthcare-associated infections. Anthim (obiltoxaximab) is used to treat anthrax, a bacterial infection caused by Bacillus anthracis, by neutralizing the anthrax toxin and preventing it from entering cells, thereby mitigating its harmful effects. For instance, in December 2023, according to report published by World Health Organization (WHO) a Switzerland based health authority, suspected anthrax cases in Zambia rose from 42 between September 2022 and January 2023 to 684 by November 20, 2023, including four deaths (0.6% CFR), across 44 districts in nine of the country's ten provinces. Therefore, the rising prevalence of bacterial infections is driving the growth of the anthim market.

Global Anthim Market Major Players

Major companies operating in the anthim market include Elusys Therapeutics Inc, Hikma Pharmaceuticals

Global Anthim Market Trend: Strategic International Contracts Enhancing Global Preparedness for Anthrax Biothreats

The key trend in the anthem market is adopting a strategic international contract approach such as public-private partnerships (PPPs) to enhance technology integration and expand market reach. Public-private partnerships (PPPs) refer to collaborations between government agencies and private pharmaceutical companies to jointly fund, research, and distribute medical treatments or drugs, often to address public health needs or stimulate innovation. For instance, in April 2022, Heat Biologics, Inc., a US-based biotechnology company, through its Elusys Therapeutics subsidiary, a US-based pharmaceutical company, secured a $5.65 million (CAD $7.9 million) contract with the Canadian government to supply ANTHIM, a treatment for inhalation anthrax, for its National Emergency Strategic Stockpile. This marks ANTHIM's first international procurement aimed at addressing anthrax biothreats amidst global geopolitical concerns. This contract is specifically for the supply of ANTHIM (obiltoxaximab), a monoclonal antibody treatment used for inhalational anthrax, which is a serious infectious disease caused by Bacillus anthracis spores.

Anthim Market Merger And Acquisition: NightHawk Biosciences Acquires Elusys Therapeutics To Strengthen Biodefense Portfolio

In April 2022, Heat Biologics, a US-based biotechnology company that offers pharmaceuticals, acquired Elusys Therapeutics for an undisclosed amount. With this acquisition, NightHawk Biosciences aims to enhance its biodefense portfolio by integrating Elusys Therapeutics' ANTHIM (obiltoxaximab) for inhalation anthrax treatment, leveraging existing government partnerships, incorporating the therapy into its RapidVax platform, improving manufacturing capabilities at its new Kansas facility, and expanding global distribution opportunities. Elusys Therapeutics is a US-based biopharmaceutical company that manufactures anthim.

Regional Outlook For The Global Anthim Market

North America was the largest region in the anthim market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthim market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anthim market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Anthim Market?

The anthim market consists of sales of monoclonal antibodies, injectable solutions and emergency response treatments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Anthim Industry?

The anthim market research report is one of a series of new reports from The Business Research Company that provides anthim market statistics, including anthim industry global market size, regional shares, competitors with a anthim market share, detailed anthim market segments, market trends, and opportunities, and any further data you may need to thrive in the anthim industry. This anthim market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anthim Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 CAGR of 7.4% from 2025 to 2034
Revenue Forecast In 2034 2024
Growth Rate 2019-2024
Base Year For Estimation 2025 - 2029 - 2034
Actual Estimates/Historical Data Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period 1) By Type: Adult, Children
2) By Clinical Indications: Inhalational Anthrax Treatment, Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax, Use In Pediatric And Adult Populations
3) By Application: Hospital, Drugs Store, Other Applications
Market Representation Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope Elusys Therapeutics Inc, Hikma Pharmaceuticals
Country Scope Request for Sample
Key Companies Profiled Explore Purchase Options
Customization Scope
Pricing And Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Anthim Market Characteristics

    3. Anthim Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Anthim Market Trends And Strategies

    5. Anthim Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Anthim Growth Analysis And Strategic Analysis Framework

    6.1. Global Anthim PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Anthim Market Growth Rate Analysis

    6.4. Global Anthim Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    6.5. Global Anthim Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    6.6. Global Anthim Total Addressable Market (TAM)

    7. Global Anthim Market Pricing Analysis & Forecasts

    8. Anthim Market Segmentation

    8.1. Global Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Adult

    Children

    8.2. Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Inhalational Anthrax Treatment

    Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax

    Use In Pediatric And Adult Populations

    8.3. Global Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital

    Drugs Store

    Other Applications

    9. Global Anthim Market Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Anthim Market Regional And Country Analysis

    10.1. Global Anthim Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. Global Anthim Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Asia-Pacific Anthim Market

    11.1. Asia-Pacific Anthim Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Asia-Pacific Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Asia-Pacific Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. China Anthim Market

    12.1. China Anthim Market Overview

    12.2. China Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.3. China Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.4. China Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    13. India Anthim Market

    13.1. India Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. India Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. India Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. Japan Anthim Market

    14.1. Japan Anthim Market Overview

    14.2. Japan Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. Japan Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. Japan Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Australia Anthim Market

    15.1. Australia Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.2. Australia Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Australia Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. South Korea Anthim Market

    16.1. South Korea Anthim Market Overview

    16.2. South Korea Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. South Korea Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.4. South Korea Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Western Europe Anthim Market

    17.1. Western Europe Anthim Market Overview

    17.2. Western Europe Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Western Europe Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.4. Western Europe Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. UK Anthim Market

    18.1. UK Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. UK Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. UK Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Germany Anthim Market

    19.1. Germany Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Germany Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Germany Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. France Anthim Market

    20.1. France Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. France Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. France Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Anthim Market

    21.1. Eastern Europe Anthim Market Overview

    21.2. Eastern Europe Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. North America Anthim Market

    22.1. North America Anthim Market Overview

    22.2. North America Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. North America Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.4. North America Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. USA Anthim Market

    23.1. USA Anthim Market Overview

    23.2. USA Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. USA Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. USA Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. Canada Anthim Market

    24.1. Canada Anthim Market Overview

    24.2. Canada Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. Canada Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. Canada Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. South America Anthim Market

    25.1. South America Anthim Market Overview

    25.2. South America Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. South America Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. South America Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. Middle East Anthim Market

    26.1. Middle East Anthim Market Overview

    26.2. Middle East Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. Middle East Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. Middle East Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Africa Anthim Market

    27.1. Africa Anthim Market Overview

    27.2. Africa Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Africa Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.4. Africa Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Anthim Market Competitive Landscape And Company Profiles

    28.1. Anthim Market Competitive Landscape

    28.2. Anthim Market Company Profiles

    28.2.1. Elusys Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

    29. Global Anthim Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Anthim Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Anthim Market

    32. Recent Developments In The Anthim Market

    33. Anthim Market High Potential Countries, Segments and Strategies

    33.1 Anthim Market In 2029 - Countries Offering Most New Opportunities

    33.2 Anthim Market In 2029 - Segments Offering Most New Opportunities

    33.3 Anthim Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Anthim Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Anthim Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Asia-Pacific, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: China, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: India, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: India, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Japan, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Japan, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Australia, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: South Korea, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: South Korea, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: South Korea, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Western Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Western Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Western Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: UK, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: UK, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: UK, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Germany, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Germany, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Germany, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: France, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: France, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: France, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Eastern Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Eastern Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Eastern Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: North America, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: North America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: North America, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: USA, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: USA, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: USA, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Canada, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Canada, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Canada, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: South America, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: South America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: South America, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Middle East, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Middle East, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Middle East, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Africa, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Africa, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Africa, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Elusys Therapeutics Inc Financial Performance
  • Table 60: Hikma Pharmaceuticals Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Anthim Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Anthim Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Asia-Pacific, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: China, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: India, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: India, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Japan, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Japan, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Australia, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: South Korea, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: South Korea, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: South Korea, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Western Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Western Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Western Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: UK, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: UK, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: UK, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Germany, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Germany, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Germany, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: France, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: France, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: France, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Eastern Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Eastern Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Eastern Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: North America, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: North America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: North America, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: USA, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: USA, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: USA, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Canada, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Canada, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Canada, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: South America, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: South America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: South America, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Middle East, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Middle East, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Middle East, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Africa, Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Africa, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Africa, Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Elusys Therapeutics Inc Financial Performance
  • Figure 60: Hikma Pharmaceuticals Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the CNS drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

Inhalation Anesthesia Global Market Report 2025 – By Product (Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide), By Application (Induction, Maintenance), By End User (Hospitals, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Inhalation And Nasal Spray Generic Drugs Global Market Report 2025 – By Drug Class( Corticosteroids, Bronchodilators, Antihistamines, Combinations, Decongestant Sprays), By Indication( Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, Other Indications), By Patient Demographics( Geriatric Patient, Adult Patient, Pediatric Patient), By End-User( Hospitals, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Inhalation Sedatives Global Market Report 2025 – By Product (Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide), By Application (Induction, Maintenance), By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Inhalation CDMO Global Market Report 2025 – By Product (Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis), By Technology (Manual Inhalers (SMI), Digital Inhalers), By End-User (Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Antiglaucoma Drugs Global Market Report 2025 – By Type (Hospital Prescription drugs, Over-the counter drugs), By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Other Types), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Parkinson Drugs Global Market Report 2025 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs ), By Route of Administration (Oral, Injection, Transdermal ), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Thyroid Drugs Global Market Report 2025 – By Drug Type (Thionamides (Inhibition of hormone synthesis), Iodides (Inhibition of hormone release)), By Route of Administration (Oral, Intravenous, Other Route of Administration), By Distribution Channel (Wholesaler/Distributors, Retail Chain, Online Distribution, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Anthim market?

Anthim is a monoclonal antibody used to treat inhalational anthrax caused by Bacillus anthracis infection. It works by binding to the anthrax toxin, preventing it from entering cells and causing damage. For further insights on the Anthim market, request a sample here

How will the Anthim market drivers and restraints affect the market dynamics? What forces will shape the Anthim industry going forward?

The Anthim market major growth driver - Impact Of Rising Bacterial Disease Prevalence On The Growth Of The ANTHIM Market. For further insights on the Anthim market, request a sample here

What is the forecast market size or the forecast market value of the Anthim market?

The Anthim market size has grown strongly in recent years. The anthim market size has grown strongly in recent years. It will grow from $3,994.45 million in 2024 to $4,300.44 million in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to government initiatives for emergency stockpiling, advancements in monoclonal antibody production technologies, heightened global awareness of biological threats, and the rising need for innovative therapeutic approaches in infectious disease management. The anthim market size is expected to see strong growth in the next few years. It will grow to $5,715.28 million in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to enhancing monoclonal antibody production, expanding healthcare infrastructure in emerging markets, and increasing global awareness of biological threat mitigation strategies. Major trends in the forecast period include advanced biopharmaceutical research, expanding public-private partnerships in biodefense initiatives, rising regional diversification in pharmaceutical production, and an emphasis on streamlined regulatory pathways to accelerate drug approval processes. For further insights on the Anthim market, request a sample here

How is the Anthim market segmented?

The anthimmarket covered in this report is segmented –
1) By Type: Adult; Children
2) By Clinical Indications: Inhalational Anthrax Treatment; Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax; Use In Pediatric And Adult Populations
3) By Application: Hospital; Drugs Store; Other Applications For further insights on the Anthim market, request a sample here

Which region has the largest share of the Anthim market? What are the other regions covered in the report?

North America was the largest region in the anthim market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthim market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Anthim market, request a sample here.

Who are the major players in the Anthim market?

Major companies operating in the anthim market include Elusys Therapeutics Inc, Hikma Pharmaceuticals . For further insights on the Anthim market, request a sample here.

What are the key trends in the Anthim market?

Major trends in the Anthim market include Strategic International Contracts Enhancing Global Preparedness for Anthrax Biothreats. For further insights on the Anthim market, request a sample here.

What are the major opportunities in the Anthim market? What are the strategies for the Anthim market?

For detailed insights on the major opportunities and strategies in the Anthim market, request a sample here.

How does the Anthim market relate to the overall economy and other similar markets?

For detailed insights on Anthim's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Anthim industry?

For detailed insights on the mergers and acquisitions in the Anthim industry, request a sample here.

What are the key dynamics influencing the Anthim market growth? SWOT analysis of the Anthim market.

For detailed insights on the key dynamics influencing the Anthim market growth and SWOT analysis of the Anthim industry, request a sample here.